Eris Lifesciences Limited IPO (Eris Lifesciences IPO) Detail

Jun 16, 2017 - Jun 20, 2017

Incorporated in 2007, Eris Lifescience Ltd is Ahmedabad, Gujrat based pharmaceutical company engaged in research, development, manufacturing and selling of select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris product portfolio is primarily focused on therapeutic areas which require the intervention of super specialist and specialist doctors such as Diabetologists, Endocrinologists Cardiologists, and Gastroenterologists.

Eris products in the chronic category cater primarily to the therapeutic areas including cardiovascular, anti-diabetics and neurology, chronic respiratory and chronic pain (analgesics).

In acute category, the product portfolio includes vitamins, gastroenterology, anti-infectives, gynaecology, cute respiratory, acute pain (analgesics), hepatoprotectives, hormones, hematology, dermatology, anti-obesity products and products for injury healing.

Eris Lifescience own and operate a manufacturing facility in Guwahati, Assam. They also outsource the manufacturing of certain of its products to 20 manufacturers. Eris strong sales team comprised of 1,310 marketing representatives.

Eris Lifescience Strengths:

• Focus on branded prescription based pharmaceutical products catering to lifestyle related disorders
• Portfolio of high volume and leading brands
• Focus on metro cities and class 1 towns in India which have higher incidence of lifestyle disorders and concentration of specialists and super specialists
• Multi-faceted product selection and engagement model leading to growth in prescription
• Strong sales, marketing and distribution capabilities

Company Promoters:

The Promoters of the Company are:
1. Mr. Amit Indubhushan Bakshi,
2. Mr. Himanshu Jayantbhai Shah,
3. Mr. Inderjeet Singh Negi,
4. Mr. Rajendrakumar Rambhai Patel and
5. Mr. Kaushal Kamlesh Shah.

Company Financials:

Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63

Objects of the Issue:

The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the sale of up to 28,875,000 Equity Shares by the Selling Shareholders.

Eris Lifesciences IPO Details

IPO Opening Date Jun 16, 2017
IPO Closing Date Jun 20, 2017
Issue Type Book Built Issue IPO
Face Value ₹1 per equity share
IPO Price ₹600 to ₹603 per equity share
Market Lot 24 Shares
Min Order Quantity 24 Shares
Listing At BSE, NSE
Issue Size28,875,000 Eq Shares of ₹1
(aggregating up to ₹1,741.16 Cr)
Offer for Sale28,875,000 Eq Shares of ₹1
(aggregating up to ₹[.] Cr)
Employee Discount ? 60 per share

Eris Lifesciences IPO Tentative Timetable

The Eris Lifesciences IPO open date is Jun 16, 2017, and the close date is Jun 20, 2017. The issue may list on Jun 29, 2017.

IPO Open Date Jun 16, 2017
IPO Close Date Jun 20, 2017
Basis of Allotment Date Jun 23, 2017
Initiation of Refunds Jun 27, 2017
Credit of Shares to Demat Account Jun 28, 2017
IPO Listing Date Jun 29, 2017

Eris Lifesciences IPO Lot Size

The Eris Lifesciences IPO market lot size is 24 shares. A retail-individual investor can apply for up to 13 lots (312 shares or ₹188,136).

Application Lots Shares Amount (Cut-off)
Minimum 1 24 ₹14,472
Maximum 13 312 ₹188,136

Eris Lifesciences IPO Subscription Status (Bidding Detail)

The Eris Lifesciences IPO is subscribed 3.29 times on Jun 20, 2017 17:00. The public issue subscribed 3.51 in the retail category, 4.68 in the QIB category, and 0.45 in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)










Eris Lifesciences IPO Prospectus

Eris Lifesciences IPO Rating

Rating:Rated 4.0 stars
Vote Here ...

Eris Lifesciences IPO Listing Date

Listing Date Thursday, June 29, 2017
BSE Script Code 540596
Listing In B Group of Securities
ISIN INE406M01024
IPO Price ₹603 per equity share
Face Value ₹1 per equity share

Listing Day Trading Information

IPO Price
Last Trade

Company Contact Information

Eris Lifesciences Limited
7th Floor, Commerce House IV,
Beside Shell Petrol Pump, 100 Feet Road,
Prahladnagar, Ahmedabad 380 015
Phone: +91 79 3045 1111

Eris Lifesciences IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270

Eris Lifesciences IPO Reviews / Ratings

  • Angel Broking - Apply
  • Choice Equity Broking Pvt Ltd - Avoid
  • Dilip Davda - Apply
  • Hem Securities - Apply
  • ICICI Direct - Apply
  • S P Tulsian - Apply

Eris Lifesciences IPO FAQs

Eris Lifesciences IPO is a main-board IPO of 28,875,000 equity shares of the face value of ₹1 aggregating up to ₹1,741.16 Crores. The issue is priced at ₹600 to ₹603 per equity share. The minimum order quantity is 24 Shares.

The IPO opens on Jun 16, 2017, and closes on Jun 20, 2017.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

The Eris Lifesciences IPO opens on Jun 16, 2017 and closes on Jun 20, 2017.

Eris Lifesciences IPO lot size is 24 Shares and the minimum order quantity is 24 Shares.

You can apply in Eris Lifesciences IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Eris Lifesciences IPO will be done on Jun 23, 2017, and the allotted shares will be credited to your demat account by Jun 28, 2017. Check the Eris Lifesciences IPO allotment status.

The Eris Lifesciences IPO listing date is on Thursday, June 29, 2017.

Eris Lifesciences IPO Message Board

Ranked Members  Ranked Members

585. ipobazaar |Aug 11, 2017 09:53
very poor listing....thats why GMP never guide please dont blame on market condition..SiS was listed yesterday and atleast opened on higher notes not like cochin shipyard...
i am lucky that i did not get allotment in shipyard...lets see what happens after listing...
584. VINAYERH |Aug 9, 2017 19:27
Chek for AFHPK6980P
583. ASNI |Aug 8, 2017 17:52
583.1. Compounder |Aug 9, 2017 01:39
Decision to sell or hold depends on your holding period. On a v conservative basis, expect the next 3 year CAGR growth to be @ 25% (2017 PAT growth was 79%) which will take the EPS to Rs. 34.3 per share. Even at a P/E multiple of 35 (reasonable for a company with 25% earnings growth and secular domestic consumption story), this stock will be at minimum Rs. 1200 by FY 20. That''s a whopping 117% return from the current price. If this return does not satisfy some people, not sure what does. This is a long term coumpounding machine run by owner operator who has skin in the game. Just hold tight for the next 2 quarters at least till the results are out and see the magic.
582. Ajmera |Aug 5, 2017 18:35
target may be appox. 940-1000 in 3-4 month
581. Tarun D Agrawal |Jul 30, 2017 16:53
Will the share price go up?
581.1. Mr. Ghosh |Jul 30, 2017 17:27
Wait for few days.
580. RT |Jul 26, 2017 21:20
Eris and Laurus both are going down.
579. DSR |Jul 24, 2017 23:16
Top Contributor Top Contributor (300+ Posts, 200+ Likes)
This is now close to open price. I believe for those wh did not get allotment now is the god time t buy or ..should wait more for the market to correct...secondary market has become too risky ..
578. SACHIN MEHTA |Jul 19, 2017 16:58
Hello Sapta Sir and Eagle eye Mam...Please suggest me about Eris Lifescience..Whether we hold or sell the stock..and if hold how much time to hold for good return...and what is your views on this stock?
578.1. Raynmaker |Jul 19, 2017 17:17
Wait till the first result, minimum.
577. Compounder |Jul 16, 2017 02:14
Great to see Eris on top of MF''s buying list.

Disclosure: Invested as HNI in IPO.
576. Dn |Jul 14, 2017 12:54
Bought 50 shares@714 & another 50 shares @ 702
Hold or sell
576.1. Prem Nookala |Jul 14, 2017 17:19
It''s a good equity fundamentally. You could go for longterm.
575. nicks Jain |Jul 14, 2017 10:49
IPO Mentor IPO Mentor (600+ Posts, 800+ Likes)
Definitely good Stocks to keep in Portfolio.
Its only for long term investors....
574. wow |Jul 14, 2017 09:08
its zooming now
573. AHM |Jul 13, 2017 21:26
Eris Life science Fundamentally Good company
One can continue to hold for ST/MT.

Tomorrow again we will upside
Today closing price 676.95
572. RT |Jul 13, 2017 19:39
I am Eris Lifesciences and now my turn to show the game.
571. BestAnalyst |Jul 6, 2017 20:17
Eris is not moving ... And tejas is running like a horse.
571.1. Raynmaker |Jul 13, 2017 15:48
Check now
571.2. nicks Jain |Jul 13, 2017 16:13
IPO Mentor IPO Mentor (600+ Posts, 800+ Likes)
In Equity mkt, lots of patience Needed
Just Like in ERIS,we were sure and confident to keep hold
570. nicks Jain |Jul 13, 2017 16:06
IPO Mentor IPO Mentor (600+ Posts, 800+ Likes)
Eris rocks today
Still holding 7 lots of IPO
569. Raynmaker |Jul 13, 2017 15:38
37 L shares traded today and Closed At 696, up 12.6%. Where are the people who were waiting to buy at 550-570?
@Septa ji profits Mubarak ho.
I am still holding and will not sell below 1,000
568. Raynmaker |Jul 6, 2017 07:52
Delivery volume since last two days over 50%. Yesterday jumped to 62%
568.2. Raynmaker |Jul 6, 2017 14:00
Now that AU allocation is out and funds will be released, let''s see how this one behaves. Allocation has been low in HNI
568.3. Raynmaker |Jul 11, 2017 15:41
Hit a High of 632. It was magical. Just zoomed and zoomed and zoomed. Still holding, wont let go below 1,000, whatever time it takes.
567. DSR |Jul 9, 2017 20:52
Top Contributor Top Contributor (300+ Posts, 200+ Likes)
One off track question:

I am using HDFsec for trading: My demat account, trading and savings account all are with HDFC.

I am now thinking of opening demat account for my wife. Could anyone suggest where should I open it ? And would it be possible to use the new account for trading through HDFCsec?
566. Chem cho |Jun 29, 2017 10:19
IPO Guru IPO Guru (2200+ Posts, 2300+ Likes)
Good buy at Rs 560 to Rs 570
wait and watch
I always come on site at time of listing ,
where experts do not dare to give comments from 10 am to 3 pm

bye no more time to spare in this site
566.13. Maniac |Jul 5, 2017 16:58
@ Shareview

Thanks mate ...:)
566.14. Raynmaker |Jul 13, 2017 10:21
Chem cho did you buy any at 560-570?